Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$20.2 billion.

  • Sanofi's Operating Expenses fell 1425.21% to -$20.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$43.7 billion, marking a year-over-year decrease of 4359.16%. This contributed to the annual value of -$18.4 billion for FY2025, which is 1174.49% down from last year.
  • Sanofi's Operating Expenses amounted to -$20.2 billion in Q4 2025, which was down 1425.21% from -$14.4 billion recorded in Q3 2025.
  • Over the past 5 years, Sanofi's Operating Expenses peaked at -$4.1 billion during Q1 2024, and registered a low of -$20.2 billion during Q4 2025.
  • Over the past 5 years, Sanofi's median Operating Expenses value was -$4.5 billion (recorded in 2022), while the average stood at -$7.7 billion.
  • As far as peak fluctuations go, Sanofi's Operating Expenses tumbled by 655654.27% in 2021, and later soared by 928.98% in 2024.
  • Quarter analysis of 5 years shows Sanofi's Operating Expenses stood at -$5.0 billion in 2021, then plummeted by 253.17% to -$17.5 billion in 2022, then rose by 5.32% to -$16.6 billion in 2023, then fell by 6.63% to -$17.7 billion in 2024, then decreased by 14.25% to -$20.2 billion in 2025.
  • Its Operating Expenses stands at -$20.2 billion for Q4 2025, versus -$14.4 billion for Q3 2025 and -$4.7 billion for Q2 2025.